InMed Pharmaceuticals (INM) Work In Process (2022 - 2025)
InMed Pharmaceuticals (INM) posted quarterly Work In Process of $569262.0 for Q4 2025, up 122.37% year-over-year from $255992.0 in Q4 2024, and up 34.64% quarter-over-quarter from $422798.0 in Q3 2025.
InMed Pharmaceuticals (INM) Work In Process (2022 - 2025) Analysis & Trends
InMed Pharmaceuticals' Work In Process history runs 4 years deep, the most recent figure standing at $569262.0 for Q4 2025.
- In Q4 2025, Work In Process rose 122.37% year-over-year to $569262.0; the TTM figure through Dec 2025 stood at $569262.0 (up 122.37% YoY), while the FY2025 annual figure was $26695.0, down 13.38% from the prior year.
- Work In Process for Q4 2025 stood at $569262.0, up from $422798.0 in the prior quarter.
- The five-year high for Work In Process was $1.7 million in Q2 2022, with the low at $18446.0 in Q3 2024.
- The 4-year median for Work In Process is $373256.0 (2025), against an average of $424701.1.
- The sharpest annual moves came in 2024 and 2025: Work In Process plunged 94.01% in 2024, then jumped 2192.09% in 2025.
- InMed Pharmaceuticals' Work In Process stood at $798813.0 in 2022, then sank by 76.59% to $186980.0 in 2023, then surged by 36.91% to $255992.0 in 2024, then surged by 122.37% to $569262.0 in 2025.
- Business Quant data shows INM's Work In Process at $569262.0 in Q4 2025, $422798.0 in Q3 2025, and $26695.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | InMed Pharmaceuticals | 6.38 Mn | 1.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 569,262.00 |
| Sep 30, 2025 | 422,798.00 |
| Jun 30, 2025 | 26,695.00 |
| Mar 31, 2025 | 323,714.00 |
| Dec 31, 2024 | 255,992.00 |
| Sep 30, 2024 | 18,446.00 |
| Jun 30, 2024 | 30,817.00 |
| Mar 31, 2024 | 439,086.00 |
| Dec 31, 2023 | 186,980.00 |
| Sep 30, 2023 | 85,655.00 |
| Jun 30, 2023 | 514,113.00 |
| Mar 31, 2023 | 548,593.00 |
| Dec 31, 2022 | 798,813.00 |
| Jun 30, 2022 | 1.72 Mn |